A PYMNTS Company

Paul, Weiss Adds Veteran Antitrust Lawyer to Washington Office

By  |  February 2, 2026

Paul, Weiss, Rifkind, Wharton & Garrison LLP said it has expanded its antitrust bench with the arrival of Jesse Solomon as a partner in its Washington, D.C., office, according a a statement released by the firm. The move places a merger and investigations adviser in the heart of the firm’s regulatory practice at a time when global competition scrutiny is intensifying, per a statement.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Solomon brings experience handling domestic and international merger reviews, investigations and conduct matters that do not involve mergers, according a statement. Firm leaders said his background fits squarely with the firm’s strategy of deepening its Washington antitrust capabilities, per a statement.

    “Jesse has significant experience across the spectrum of critical antitrust matters, and we are thrilled to welcome him to our growing Washington antitrust team,” said Paul, Weiss Chairman Brad S. Karp. “His proven ability to secure clearances for multibillion-dollar mergers will be an invaluable asset to our clients as they navigate the increased global regulatory scrutiny of major transactions.”

    Scott A. Sher, the firm’s global co-chair of the Antitrust Practice, echoed that sentiment, according a statement. “We are delighted to welcome Jesse, whose stature in the antitrust bar and extraordinary track record before the FTC and DOJ set him apart,” Sher said. “His proven success guiding clients through complex merger clearances and investigations will be a tremendous asset to our clients, who require the most sophisticated antitrust counsel.”

    Read more: Paul, Weiss Expands Antitrust Team with Hires in Washington

    Solomon is a regular presence before the Federal Trade Commission and the U.S. Department of Justice, where he represents companies in both merger and non-merger investigations, according a a statement. In deal work, he is known for crafting global strategies designed to obtain approvals across multiple jurisdictions, per a statement.

    Among his past matters are a number of multibillion-dollar transactions in life sciences and healthcare, including Aetna’s sale to CVS Health, Shire’s acquisition by Takeda, and deals involving AstraZeneca, Bristol Myers Squibb and GSK plc, according a a statement. His work in other sectors has included advising ICM Partners on its acquisition of Creative Artists Agency after an extended DOJ review, Campbell Soup’s purchase of Sovos Brands, and Nuvei’s acquisition of Paya Holdings, per a statement. He has also led major conduct investigations and litigation, including a recent high-impact case for Syngenta, according a a statement.

    Solomon’s career has been marked by industry recognition, with honors from Chambers USA for Antitrust in Washington, D.C., and Legal 500 U.S. as a Next Generation Partner in Antitrust: Merger Control, per a statement. He has also been named a “D.C. Rising Star” by the National Law Journal, according a a statement.

    His academic background includes a law degree from UC Berkeley School of Law, where he was elected to the Order of the Coif and served as Senior Notes and Comments Editor of the California Law Review, per a statement. He also holds a master’s degree and a bachelor’s degree, both summa cum laude, in English Literature from Emory University, according a a statement.

    Paul, Weiss’s Antitrust Practice handles a broad slate of competition matters worldwide, from regulatory clearances and government investigations to private litigation and compliance counseling, per a statement. The firm appears before antitrust authorities in the United States, the European Union, the United Kingdom and other jurisdictions, underscoring the global scope of the work Solomon is expected to support, according a a statement.

    Source: Paul Weiss